Search research articles
Contact Us
Filters
Showing results (21-30 of 96) with videos related to
Page
of 10
Sort By:
European Journal of Medicinal Chemistry
|
August 21, 2018
Recent advances in small molecule based cancer immunotherapy
Binbin Cheng, Wei-En Yuan, Jing Su, et al.
Journal of Medicinal Chemistry
|
February 16, 2026
Discovery of Novel Heterotetracyclic DNA-Dependent Protein Kinase (DNA-PK) Inhibitors with Improved Oral Bioavailability and Potent Cancer Immunotherapy-Potentiating Activity
Bingsheng Guan, Binbin Cheng, Shiyun Cheng, et al.
European Journal of Medicinal Chemistry
|
April 25, 2022
Discovery of novel 7,8-dihydropteridine-6(5H)-one-based DNA-PK inhibitors as potential anticancer agents via scaffold hopping strategy
Zongbao Ding, Wei Pan, Yao Xiao, et al.
Biochimica Et Biophysica Acta. Reviews on Cancer
|
September 5, 2024
Bioactive sphingolipids as emerging targets for signal transduction in cancer development
Wentao Jia, Jiaying Yuan, Jinbo Zhang, et al.
Journal of Hepatocellular Carcinoma
|
March 18, 2024
A Hypoxia-Related miRNA-mRNA Signature for Predicting the Response and Prognosis of Transcatheter Arterial Chemoembolization in Hepatocellular Carcinoma
Shaoqi Zong, Guokai Huang, Bo Pan, et al.
Food and Chemical Toxicology : an International Journal Published for the British Industrial Biological Research Association
|
March 6, 2012
Ginsenoside Rb1 inhibits osteoclastogenesis by modulating NF-κB and MAPKs pathways
Binbin Cheng, Jun Li, Juan Du, et al.
Disease Markers
|
July 8, 2021
m<sup>6</sup>A RNA Methylation Regulators Elicit Malignant Progression and Predict Clinical Outcome in Hepatocellular Carcinoma
Wenli Li, Jun Liu, Zhanzhong Ma, et al.
The New Microbiologica
|
January 22, 2024
Clinical characteristics of 14 cases of Chlamydia psittaci pneumonia
Binbin Cheng, Jun Wang, Lin Lin, et al.
European Journal of Medicinal Chemistry
|
January 20, 2022
Recent advances in DDR (DNA damage response) inhibitors for cancer therapy
Binbin Cheng, Wei Pan, Yi Xing, et al.
European Journal of Medicinal Chemistry
|
December 30, 2024
Recent advances in developing targeted protein degraders
Binbin Cheng, Hongqiao Li, Xiaopeng Peng, et al.
Page
of 10
Search research articles
Search
Showing results (21-30 of 96) with videos related to
Sort By:
Page
of 10
European Journal of Medicinal Chemistry
|
August 21, 2018
Recent advances in small molecule based cancer immunotherapy
Binbin Cheng, Wei-En Yuan, Jing Su, et al.
Journal of Medicinal Chemistry
|
February 16, 2026
Discovery of Novel Heterotetracyclic DNA-Dependent Protein Kinase (DNA-PK) Inhibitors with Improved Oral Bioavailability and Potent Cancer Immunotherapy-Potentiating Activity
Bingsheng Guan, Binbin Cheng, Shiyun Cheng, et al.
European Journal of Medicinal Chemistry
|
April 25, 2022
Discovery of novel 7,8-dihydropteridine-6(5H)-one-based DNA-PK inhibitors as potential anticancer agents via scaffold hopping strategy
Zongbao Ding, Wei Pan, Yao Xiao, et al.
Biochimica Et Biophysica Acta. Reviews on Cancer
|
September 5, 2024
Bioactive sphingolipids as emerging targets for signal transduction in cancer development
Wentao Jia, Jiaying Yuan, Jinbo Zhang, et al.
Journal of Hepatocellular Carcinoma
|
March 18, 2024
A Hypoxia-Related miRNA-mRNA Signature for Predicting the Response and Prognosis of Transcatheter Arterial Chemoembolization in Hepatocellular Carcinoma
Shaoqi Zong, Guokai Huang, Bo Pan, et al.
Food and Chemical Toxicology : an International Journal Published for the British Industrial Biological Research Association
|
March 6, 2012
Ginsenoside Rb1 inhibits osteoclastogenesis by modulating NF-κB and MAPKs pathways
Binbin Cheng, Jun Li, Juan Du, et al.
Disease Markers
|
July 8, 2021
m<sup>6</sup>A RNA Methylation Regulators Elicit Malignant Progression and Predict Clinical Outcome in Hepatocellular Carcinoma
Wenli Li, Jun Liu, Zhanzhong Ma, et al.
The New Microbiologica
|
January 22, 2024
Clinical characteristics of 14 cases of Chlamydia psittaci pneumonia
Binbin Cheng, Jun Wang, Lin Lin, et al.
European Journal of Medicinal Chemistry
|
January 20, 2022
Recent advances in DDR (DNA damage response) inhibitors for cancer therapy
Binbin Cheng, Wei Pan, Yi Xing, et al.
European Journal of Medicinal Chemistry
|
December 30, 2024
Recent advances in developing targeted protein degraders
Binbin Cheng, Hongqiao Li, Xiaopeng Peng, et al.
Page
of 10